News
-
-
PRESS RELEASE
BioVersys receives EMA Orphan Designation for the combination of alpibectir and ethionamide for the treatment of tuberculosis
BioVersys receives EMA Orphan Designation for the combination of alpibectir and ethionamide for the treatment of tuberculosis. The designation provides key incentives for addressing drug resistance in TB treatment -
PRESS RELEASE
FamiCord AG significantly increases revenue and earnings in the first half of 2025 and shifts focus even more strongly to core business in the future
FamiCord AG reports 14.6% revenue growth and EUR 5.0 million rise in EBITDA for H1 2025. Focus shifts to core business. Outlook affirmed amid market challenges -
PRESS RELEASE
Branicks Group AG: Strong operating business, consolidation in track and significantly improved consolidated earnings in the first half of the financial year
Branicks Group AG reports strong operating business and significantly improved consolidated earnings in the first half of the financial year 2025 -
PRESS RELEASE
VIB with strong growth in the first half of 2025 – Increase in both gross rental income and FFO
VIB Vermögen AG reports strong growth in first half of 2025 with significant increases in gross rental income and FFO. Strategic developments include portfolio diversification and acquisition of Branicks' institutional business -
-
PRESS RELEASE
Aroundtown announces H1 2025 results demonstrating a strong balance sheet, paving the way for opportunistic growth
Aroundtown announces strong H1 2025 results with stable net rental income and adjusted EBITDA. Balance sheet shows decreased LTV to 40% and successful bond issuances, aiming for growth opportunities -
-
-
PRESS RELEASE
Accelleron Industries AG: Accelleron, propelled by high demand and market share gains, reports outstanding half-year results
Accelleron Industries AG reports outstanding half-year results with revenues increasing by 20.3%, operational EBITA rising to USD 154.9 million, and net income at USD 114.7 million
